Jesse Stewart of the School of Science and two colleagues have received a $2.2 million National Institutes of Health grant to investigate the links between depression, depression treatment and cardiovascular disease in adults with HIV. With the success of antiretroviral therapy, cardiovascular disease is now the leading cause of death in HIV-infected adults.
A NEW £1million research center funded by the Leverhulme Trust at the University of Huddersfield will train the next generation of specialists in a field that uses the latest DNA science to delve into evolutionary history, from the origins of animals to the spread of modern humans.
Electronic medication monitoring caps may help physicians put together the puzzle of why children taking a medicine that promises to curb sickle cell disease are showing mixed, confusing results.
Business Secretary Vince Cable has announced £40 million investment in UK synthetic biology at the Manchester Institute for Biotechnology.
The George Washington University Cancer Institute received a $97,000 grant from Genentech to address health disparities in cancer care.
Researchers are developing a design framework that will help speed the design of powered exoskeletons for the lower body. The modeling will enable highly customized exoskeletons that give disabled persons natural motion with better comfort and safety. The devices will also allow military personnel and construction workers to carry heavy loads over long distances.
Mayo Clinic's campus in Jacksonville, Fla., has received a $5.75 million gift from the Harry T. Mangurian Jr. Foundation in Palm Beach, Fla., to advance the study of Lewy body dementia, a deadly disease that causes a progressive decline in mental and physical abilities. The new Mayo program is one of a few in the world dedicated to finding answers and treatments for the disease.
The German Research Foundation will fund four new clinical trials following a decision by its Joint Committee. The trials will enable researchers to address current, urgent questions in patient-oriented clinical research within the framework of a controlled interventional trial.
To reduce or eliminate false positive results from the quickest and most sensitive Ebola test, researchers will make a positive control for processing Ebola DNA. The control will be made of non-infectious sequences of Ebola Virus nucleic acid tucked inside a plant virus' protective protein shell.
Gurpreet Singh, assistant professor of mechanical and nuclear engineering at Kansas State University, has received a $500,000 National Science Foundation CAREER award for his nanotechnology research.